EMEA-000981-PIP01-10-M04
Key facts
| Active substance |
Ozenoxacin
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0167/2014
|
| PIP number |
EMEA-000981-PIP01-10-M04
|
| Pharmaceutical form(s) |
Cream
|
| Condition(s) / indication(s) |
Treatment of impetigo
|
| Route(s) of administration |
Cutaneous use
|
| Contact for public enquiries |
Ferrer Internacional S.A
Spain
E-mail: silviamartin@ferrergrupo.com, ccasadoc@ferrergrupo.com Tel. +34 9350 93227, +34 935093289 Fax +34 9350 93270 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000981-PIP01-10-M04
|
| Compliance opinion date |
29/01/2016
|
| Compliance outcome |
positive
|